Skip to main content
Erschienen in: International Journal of Clinical Oncology 5/2016

12.05.2016 | Original Article

Putative risk factors for postoperative pneumonia which affects poor prognosis in patients with gastric cancer

verfasst von: Jun Kiuchi, Shuhei Komatsu, Daisuke Ichikawa, Toshiyuki Kosuga, Kazuma Okamoto, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Tomoyo Yasuda, Eigo Otsuji

Erschienen in: International Journal of Clinical Oncology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Background and objectives

Several recent studies identified that postoperative infectious complications contribute to recurrence and poor outcome in patients with gastric cancer. This study was designed to investigate the prognostic impact of postoperative pneumonia, and to identify the putative risk factors for its occurrence.

Methods

We retrospectively analyzed 1,415 consecutive patients who underwent curative gastrectomy for gastric cancer between 1997 and 2013.

Results

A total of 31 (2.2 %) patients developed postoperative pneumonia (Clavien–Dindo classification ≥II). Patients with postoperative pneumonia showed a significantly poorer prognosis than patients without (P < 0.001). Concerning the occurrence of postoperative pneumonia, univariate and multivariate analyses identified older age (≥65 years; P = 0.010; odds ratio [OR] 3.59), lower nutritious status (albumin <3 0; P = 0.029; OR 4.51), advanced stage (pStage ≥II; P = 0.045; OR 2.35), concurrent hypertension (P = 0.042; OR 2.21) and total gastrectomy (P = 0.026; OR 2.42) as independent risk factors.

Conclusions

Postoperative pneumonia was shown to be associated with long-term poor outcome in patients with gastric cancer. Care should be taken for patients with clinical factors such as older age, lower nutritional status, advanced stage, concurrent hypertension, and total gastrectomy.
Literatur
1.
Zurück zum Zitat Ferlay J, Shin HR, Bray F et al (2008) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRef Ferlay J, Shin HR, Bray F et al (2008) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRef
2.
Zurück zum Zitat The Foundation for Promotion of Cancer Research (FPCR) (2013) Cancer statistics in Japan The Foundation for Promotion of Cancer Research (FPCR) (2013) Cancer statistics in Japan
3.
Zurück zum Zitat Zhang Q, Wang F, Chen ZY et al (2015) Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow band imaging for early gastric cancer: a meta-analysis. Gastric Cancer 19(2):543–552CrossRefPubMed Zhang Q, Wang F, Chen ZY et al (2015) Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow band imaging for early gastric cancer: a meta-analysis. Gastric Cancer 19(2):543–552CrossRefPubMed
4.
Zurück zum Zitat Kitano S, Shiraishi N, Uyama I, Japanese Laparoscopic Surgery Study Group et al (2007) A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg 245(1):68–72CrossRefPubMedPubMedCentral Kitano S, Shiraishi N, Uyama I, Japanese Laparoscopic Surgery Study Group et al (2007) A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg 245(1):68–72CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Komatsu S, Ichikawa D, Kashimoto K et al (2013) Risk factors to predict severe postoperative pancreatic fistula following gastrectomy for gastric cancer. World J Gastroenterol 19(46):8696–8702CrossRefPubMedPubMedCentral Komatsu S, Ichikawa D, Kashimoto K et al (2013) Risk factors to predict severe postoperative pancreatic fistula following gastrectomy for gastric cancer. World J Gastroenterol 19(46):8696–8702CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376(9742):687–697CrossRefPubMed Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376(9742):687–697CrossRefPubMed
7.
Zurück zum Zitat Lawrence VA, Hilsenbeck SG, Mulrow CD et al (1995) Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery. J Gen Intern Med 10:671–678CrossRefPubMed Lawrence VA, Hilsenbeck SG, Mulrow CD et al (1995) Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery. J Gen Intern Med 10:671–678CrossRefPubMed
8.
Zurück zum Zitat Thompson DA, Makary MA, Dorman T et al (2006) Clinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patients. Ann Surg 243(4):547–552CrossRefPubMedPubMedCentral Thompson DA, Makary MA, Dorman T et al (2006) Clinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patients. Ann Surg 243(4):547–552CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Hayashi T, Yoshikawa T, Aoyama T et al (2015) Impact of infectious complications on gastric cancer recurrence. Gastric Cancer 18(2):368–374CrossRefPubMed Hayashi T, Yoshikawa T, Aoyama T et al (2015) Impact of infectious complications on gastric cancer recurrence. Gastric Cancer 18(2):368–374CrossRefPubMed
10.
Zurück zum Zitat Tokunaga M, Tanizawa Y, Bando E et al (2013) Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol 20(5):1575–1583CrossRefPubMed Tokunaga M, Tanizawa Y, Bando E et al (2013) Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol 20(5):1575–1583CrossRefPubMed
11.
Zurück zum Zitat Ohtsuka T, Kitajima Y, Takahashi T et al (2009) Infectious complications after gastric cancer surgery accelerate a rapid hepatic recurrence. Hepatogastroenterology 56(94–95):1277–1280PubMed Ohtsuka T, Kitajima Y, Takahashi T et al (2009) Infectious complications after gastric cancer surgery accelerate a rapid hepatic recurrence. Hepatogastroenterology 56(94–95):1277–1280PubMed
12.
Zurück zum Zitat Fisher BW, Majumdar SR, McAlister FA (2002) Predicting pulmonary complications after nonthoracic surgery: a systematic review of blinded studies. Am J Med 112(3):219–225CrossRefPubMed Fisher BW, Majumdar SR, McAlister FA (2002) Predicting pulmonary complications after nonthoracic surgery: a systematic review of blinded studies. Am J Med 112(3):219–225CrossRefPubMed
13.
Zurück zum Zitat McAlister FA, Bertsch K, Man J et al (2005) Incidence of and risk factors for pulmonary complications after nonthoracic surgery. Am J Respir Crit Care Med 171(5):514–517CrossRefPubMed McAlister FA, Bertsch K, Man J et al (2005) Incidence of and risk factors for pulmonary complications after nonthoracic surgery. Am J Respir Crit Care Med 171(5):514–517CrossRefPubMed
14.
Zurück zum Zitat Inokuchi M, Kojima K, Kato K et al (2014) Risk factors for post-operative pulmonary complications after gastrectomy for gastric cancer. Surg Infect (Larchmt) 15(3):314–321CrossRef Inokuchi M, Kojima K, Kato K et al (2014) Risk factors for post-operative pulmonary complications after gastrectomy for gastric cancer. Surg Infect (Larchmt) 15(3):314–321CrossRef
15.
Zurück zum Zitat Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112CrossRef Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112CrossRef
16.
17.
Zurück zum Zitat Kodera Y, Sasako M, Yamamoto S, Gastric Cancer Surgery Study Group of Japan Clinical Oncology Group et al (2005) Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 92(9):1103–1109CrossRefPubMed Kodera Y, Sasako M, Yamamoto S, Gastric Cancer Surgery Study Group of Japan Clinical Oncology Group et al (2005) Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 92(9):1103–1109CrossRefPubMed
18.
Zurück zum Zitat Cleva R, Assumpção MS, Sasaya F et al (2014) Correlation between intra-abdominal pressure and pulmonary volumes after superior and inferior abdominal surgery. Clinics (Sao Paulo) 69(7):483–486CrossRef Cleva R, Assumpção MS, Sasaya F et al (2014) Correlation between intra-abdominal pressure and pulmonary volumes after superior and inferior abdominal surgery. Clinics (Sao Paulo) 69(7):483–486CrossRef
19.
Zurück zum Zitat Pellegrini CA, DeMeester TR, Johnson LF et al (1979) Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality, and results of surgical therapy. Surgery 86(1):110–119PubMed Pellegrini CA, DeMeester TR, Johnson LF et al (1979) Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality, and results of surgical therapy. Surgery 86(1):110–119PubMed
20.
Zurück zum Zitat Marumo K, Homma S (2005) Role of gastro-esophageal reflux (GER) and swallowing latency in aspiration pulmonary diseases. Nihon Kokyuki Gakkai Zasshi 43(6):333–339 (in Japanese) PubMed Marumo K, Homma S (2005) Role of gastro-esophageal reflux (GER) and swallowing latency in aspiration pulmonary diseases. Nihon Kokyuki Gakkai Zasshi 43(6):333–339 (in Japanese) PubMed
21.
Zurück zum Zitat Marumo K, Homma S, Fukuchi Y (1995) Postgastrectomy aspiration pneumonia. Chest 107(2):453–456CrossRefPubMed Marumo K, Homma S, Fukuchi Y (1995) Postgastrectomy aspiration pneumonia. Chest 107(2):453–456CrossRefPubMed
22.
Zurück zum Zitat Takeshita H, Ichikawa D, Komatsu S et al (2013) Surgical outcomes of gastrectomy for elderly patients with gastric cancer. World J Surg 37(12):2891–2898CrossRefPubMed Takeshita H, Ichikawa D, Komatsu S et al (2013) Surgical outcomes of gastrectomy for elderly patients with gastric cancer. World J Surg 37(12):2891–2898CrossRefPubMed
23.
Zurück zum Zitat Kawaguchi T, Komatsu S, Ichikawa D et al (2015) Clinical significance of chemotherapy for geriatric patients with advanced or recurrent gastric cancer. Mol Clin Oncol 3(1):83–88PubMed Kawaguchi T, Komatsu S, Ichikawa D et al (2015) Clinical significance of chemotherapy for geriatric patients with advanced or recurrent gastric cancer. Mol Clin Oncol 3(1):83–88PubMed
Metadaten
Titel
Putative risk factors for postoperative pneumonia which affects poor prognosis in patients with gastric cancer
verfasst von
Jun Kiuchi
Shuhei Komatsu
Daisuke Ichikawa
Toshiyuki Kosuga
Kazuma Okamoto
Hirotaka Konishi
Atsushi Shiozaki
Hitoshi Fujiwara
Tomoyo Yasuda
Eigo Otsuji
Publikationsdatum
12.05.2016
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 5/2016
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-016-0987-8

Weitere Artikel der Ausgabe 5/2016

International Journal of Clinical Oncology 5/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.